InDex Pharmaceuticals Holding AB (publ) (INDEX.ST) - Stock Prices, Stock Peers & Analysis

Home
INDEX.ST

Company Name	InDex Pharmaceuticals Holding AB (publ)
Symbol	INDEX.ST
Currency	SEK
Price	0.244
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	129,975,872
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.198 - 0.926
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Johan Gileus
Website	https://www.indexpharma.com

An error occurred while fetching data.

About InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company's lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA